Form D · Biotechnology

Lucira Health, Inc.

Emeryville, CA · CIK 0001652724

Offering snapshot reported Jan 16, 2020 · SEC filing

Reported sold
$32.5M
Offering amount: $32.5M
Investors reported
30
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 11, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$16.3M$32.5MAug 7, 2019: $15,000,000.00Aug 7, 2019Jan 16, 2020: $32,500,000.00Jan 16, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$15,000,000 → $32,500,000
  • Reported investors29 → 30

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 16, 2020Amendment$32,500,000$17,500,000vs Aug 7, 201930SEC filing
Aug 7, 2019Initial$15,000,000No comparison29SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-345969

Source: Form D, filed Jan 16, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Justin Butler Director
Erik T. Engelson Director, Executive
Debkishore Mitra Director
Steve Tablak Director
John R. Waldeisen Director
Tuff Yen Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1412 62 Nd Street
Emeryville, CA, 94608